We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Shimadzu, Toppan and Third Wave Sign Agreement for Point-of-Care Instrument

The instrument is designed to analyzing a patient's DNA for specific gene sequences.
News

Xenomics Appoints New CEO

Dr. L. David Tomei has been appointed as new CEO.
News

Ipsogen Presents Breast Cancer Biomarker Results at the EBCC 5

These results concern the identification on 323 patient samples.
News

Brain Cancer Patients Living Longer After Personalized Vaccine Therapy

Patients are surviving twice as long with DCVax®-Brain as with other therapeutics.
News

Ark’s Platform Increases Efficacy of Anti-cancer Therapies

Gene-based drug targeting platform technology, has been shown to be effective in stopping tumour development.
News

Monogram and Dana-Farber Cancer Institute Enter Collaboration Agreement

The Institute will use Monogram's eTag™ technology in preclinical and clinical oncology research studies.
News

Transgenomic's Technology Used to Detect Mutations in EGFR Gene

The presence of EGFR mutations has been shown to correlate with response to targeted therapeutics that inhibits EGFR.
News

LabCorp® Licenses the Seryx Pharmacogenetic Interpretation and Reporting Service

Proprietary service helps physicians use CYP450 information to customize medications for optimal patient treatment.
News

Integragen Appoints Gerard Vaillant as Non-Executive Director

Former Company Group Chairman of Johnson & Johnson Brings Extensive Experience into Personalised Healthcare Company.
News

Asuragen Targets Early Diagnosis and Treatment Outcome for Cancer Patients

Asuragen will leverage the RNA expertise developed by Ambion.
Advertisement